 Pravastatin vs gemfibrozil treatment primary hypercholesterolemia Italian Multicenter Pravastatin Study study efficacy safety pravastatin gemfibrozil treatment primary hypercholesterolemia eighty-five outpatients lipid clinics Italy randomized double-blind study Patients mg pravastatin mg gemfibrozil twice initial diet lead-in period weeks mean reductions baseline values plasma total low-density lipoprotein cholesterol pravastatin gemfibrozil Significant lipid-lowering effects weeks Apolipoprotein decrease pravastatin gemfibrozil significant increase high-density lipoprotein cholesterol pravastatin increase gemfibrozil Serum values pravastatin gemfibrozil Familial polygenic hypercholesterolemic patients Pravastatin effectiveness low-density lipoprotein cholesterol polygenic familial hypercholesterolemic patients Treatment patients pravastatin gemfibrozil study incidence clinical symptoms laboratory alterations low treatment groups Pravastatin gemfibrozil pravastatin effective total low-density lipoprotein cholesterol levels primary familial polygenic hypercholesterolemias gemfibrozil